Simpex R&D believes to help the patients suffering from severe diseases in the society by the help of innovation in medical science, developing intellectual property in non-infringing processes, resolving complex chemical challenges and developing of generic product in similar way as innovator.
During development of generic drugs, datamining is very important aspect in this process and we use following data sources to fulfill our requirement.
- US FDA sites
- Electronic medicines compendium (emc)
- ICH guidelines for pharmaceutical development
- ICH guideline on quality risk management
- SUPAC guidelines for scale-up and the post-approval changes
- World Patents
- US Patent
- Indian patent
- Drug bank
- Pub chem
- Reputed journals
- Office of generic drugs FDA guidelines
- Orange book
- Complete drug reference
- Handbook of pharmaceutical excipients etc.
